Name
Osaühing Interfarm Est
Registry code
11224607
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
27.02.2006 (18)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
46461 - Wholesale of medicines and other pharmacy goods
-
23 €
-
1 533 €
(estimate is approximate)
11 934 €
1
Submitted
No tax arrears
0%
0%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Osaühing Zoovetvaru 10498372 | 100% - 2 556.00 EUR | - | - | |
| Margus Kuklane 06.05.1964 (60) | - | Board member | Direct ownership | |
| Indrek - Eston Kuklane 21.02.1970 (54) | - | - | Direct ownership | |
| Jüri Kasper 12.02.1951 (73) | - | - | - | Founder |
| 2019 15.01.2021 | 2020 04.11.2021 | 2021 11.07.2022 | 2022 10.07.2023 | 2023 27.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | - | - | - | - | - |
| Net profit (loss) for the period | 153 € | 0 € | 217 € | 257 € | 23 € |
| Profit Margin | - | - | - | - | - |
| Current Assets | 13 241 € | 13 241 € | 15 809 € | 15 523 € | 14 592 € |
| Fixed Assets | - | - | 87 250 € | 0 € | - |
| Total Assets | 13 241 € | 13 241 € | 103 059 € | 15 523 € | 14 592 € |
| Current Liabilities | 1 804 € | 1 804 € | 2 365 € | 3 612 € | 2 658 € |
| Non Current Liabilities | - | - | 89 040 € | 0 € | 0 € |
| Total Liabilities | - | - | 91 405 € | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 11 437 € | 11 437 € | 11 654 € | 11 911 € | 11 934 € |
| Employees | 1 | 1 | 1 | 1 | 1 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 1 743.8 € | 1 821.7 € | 1 |
| 2023 Q4 | - | 2 052.48 € | 2 158.47 € | 1 |
| 2023 Q3 | - | 2 052.48 € | 2 158.47 € | 1 |
| 2023 Q2 | - | 1 906.7 € | 2 005.11 € | 1 |
| 2023 Q1 | - | 2 539.43 € | 2 663.44 € | 1 |
| 2022 Q4 | - | 1 894.74 € | 1 992.36 € | 1 |
| 2022 Q3 | - | 1 807.92 € | 1 902.04 € | 1 |
| 2022 Q2 | - | 1 480.77 € | 1 561.89 € | 1 |
| 2022 Q1 | - | 1 759.87 € | 1 849.56 € | 1 |
| 2021 Q4 | - | 1 279.98 € | 1 351.98 € | 1 |
| 2021 Q3 | - | 1 267.98 € | 1 399.95 € | 1 |
| 2021 Q2 | - | 1 267.98 € | 1 399.95 € | 1 |
| 2021 Q1 | - | 1 267.98 € | 1 399.95 € | 1 |
| 2020 Q4 | - | 1 267.98 € | 1 399.95 € | 1 |
| 2020 Q3 | - | 1 267.98 € | 1 399.95 € | 1 |
| 2020 Q2 | - | 1 267.98 € | 1 399.95 € | 1 |
| 2020 Q1 | - | 1 267.98 € | 1 399.95 € | 1 |
